carbon tetrachloride has been researched along with Disease Exacerbation in 92 studies
Carbon Tetrachloride: A solvent for oils, fats, lacquers, varnishes, rubber waxes, and resins, and a starting material in the manufacturing of organic compounds. Poisoning by inhalation, ingestion or skin absorption is possible and may be fatal. (Merck Index, 11th ed)
tetrachloromethane : A chlorocarbon that is methane in which all the hydrogens have been replaced by chloro groups.
| Excerpt | Relevance | Reference |
|---|---|---|
| " To explore the role of MMP-2 in hepatic fibrogenesis, we employed two fibrosis models in mice; toxin (carbon tetrachloride, CCl4)-induced and cholestasis-induced fibrosis." | 3.77 | Cholestatic liver fibrosis and toxin-induced fibrosis are exacerbated in matrix metalloproteinase-2 deficient mice. ( Funaoka, Y; Kakinuma, S; Kamiya, A; Kiyohashi, K; Koshikawa, N; Miyoshi, M; Nakagawa, M; Nakauchi, H; Onozuka, I; Sakamoto, N; Seiki, M; Ueyama, M; Watanabe, M; Watanabe, T, 2011) |
| " In the present study, we address the role of Gas6 in steatohepatitis and progression to liver fibrosis using Gas6-deficient mice fed a choline-deficient ethionine-supplemented diet (CDE) or receiving a chronic carbon tetrachloride (CCl(4)) treatment." | 3.77 | Gas6 deficiency prevents liver inflammation, steatohepatitis, and fibrosis in mice. ( Brouillet, A; Chobert, MN; Couchie, D; Fourcot, A; Laperche, Y; Mavier, P; Zafrani, ES, 2011) |
| "Obesity is associated with hyperleptinemia and is also a risk factor for fibrosis and severity of fibrosis in several chronic liver diseases." | 3.71 | Leptin is essential for the hepatic fibrogenic response to chronic liver injury. ( Farrell, GC; Leclercq, IA; Robertson, GR; Schriemer, R, 2002) |
| "Non-alcoholic steatohepatitis (NASH) is a major cause of chronic liver disease." | 1.51 | New Rat Model of Advanced NASH Mimicking Pathophysiological Features and Transcriptomic Signature of The Human Disease. ( Bosch, J; Boyer-Diaz, Z; Gracia-Sancho, J; Lozano, JJ; Maeso-Díaz, R; Ortega-Ribera, M; Peralta, C, 2019) |
| "Liver fibrosis is associated with significant collagen-I deposition largely produced by activated hepatic stellate cells (HSCs); yet, the link between hepatocyte damage and the HSC profibrogenic response remains unclear." | 1.46 | Signalling via the osteopontin and high mobility group box-1 axis drives the fibrogenic response to liver injury. ( Antoine, DJ; Arriazu, E; Ge, X; Kitamura, N; Leung, TM; Lopategi, A; Lu, Y; Magdaleno, F; Nieto, N; Theise, N; Urtasun, R, 2017) |
| " Therefore, the effects of the orally bioavailable synthetic triterpenoid 2-cyano-3,12-dioxooleana- 1,9(11)-dien-28-oate-ethyl amide (CDDO-EA, RTA 405), which has potent antioxidative and antiinflammatory properties, was evaluated in a chronic carbon tetrachloride (CCl(4))-induced model of liver cirrhosis and hepatocellular carcinoma (HCC)." | 1.43 | The Synthetic Triterpenoid RTA 405 (CDDO-EA) Halts Progression of Liver Fibrosis and Reduces Hepatocellular Carcinoma Size Resulting in Increased Survival in an Experimental Model of Chronic Liver Injury. ( Cusimano, FA; Getachew, Y; Gopal, P; Reisman, SA; Shay, JW, 2016) |
| " We studied the functional contribution of lysyl oxidase (LOX) to collagen stabilization and hepatic fibrosis progression/reversalin vivousing chronic administration of irreversible LOX inhibitor β-aminopropionitrile (BAPN, or vehicle as control) in C57Bl/6J mice with carbon tetrachloride (CCl4)-induced fibrosis." | 1.43 | Lysyl oxidase activity contributes to collagen stabilization during liver fibrosis progression and limits spontaneous fibrosis reversal in mice. ( Greenstein, A; Ikenaga, N; Liu, SB; Peng, ZW; Popov, Y; Schuppan, D; Smith, V; Sverdlov, DY, 2016) |
| "Chlordecone is a chlorinated pesticide used in the 1990s." | 1.43 | Chlordecone potentiates hepatic fibrosis in chronic liver injury induced by carbon tetrachloride in mice. ( Gelu-Simeon, M; Genet, V; Lucas-Clerc, C; Piquet-Pellorce, C; Samson, M; Tabet, E; Tiaho, F, 2016) |
| "Carbon tetrachloride (CCl4 ) was used to induce acute and chronic liver injury in TWEAK KO mice." | 1.43 | Interaction of TWEAK with Fn14 leads to the progression of fibrotic liver disease by directly modulating hepatic stellate cell proliferation. ( Adams, DH; Afford, SC; Amatucci, A; Burkly, LC; Hübscher, S; Humphreys, E; Munir, M; Resheq, Y; Reynolds, G; Shepherd, EL; Weston, CJ; Wilhelm, A, 2016) |
| "The progression of liver fibrosis, an intrinsic response to chronic liver injury, is associated with hepatic hypoxia, angiogenesis, abnormal inflammation, and significant matrix deposition, leading to the development of cirrhosis and hepatocellular carcinoma (HCC)." | 1.43 | Dual-Functional Nanoparticles Targeting CXCR4 and Delivering Antiangiogenic siRNA Ameliorate Liver Fibrosis. ( Chan, KM; Chen, Y; Chern, GG; Chiang, T; Hsu, FF; Liu, CH; Liu, JY; Liu, YC; Wu, YH, 2016) |
| "Melatonin was given at 5 or 10 mg/kg/d intraperitoneally, beginning 2 weeks after the start of CCl4 administration." | 1.42 | Melatonin limits the expression of profibrogenic genes and ameliorates the progression of hepatic fibrosis in mice. ( Crespo, I; Fernández, A; González-Gallego, J; Ortiz de Urbina, J; San-Miguel, B; Tuñón, MJ, 2015) |
| "Different stages of liver fibrosis were induced in wild-type and NS3/4A-Tg mice by single carbon tetrachloride (acute) or multiple injections for 4 (intermediate) or 8 (chronic) weeks." | 1.42 | Hepatitis C Virus Nonstructural 3/4A Protein Dampens Inflammation and Contributes to Slow Fibrosis Progression during Chronic Fibrosis In Vivo. ( Bansal, R; Brenndörfer, ED; Frelin, L; Prakash, J; Sällberg, M; Storm, G, 2015) |
| "The gold standard in assessing liver fibrosis is biopsy despite limitations like invasiveness and sampling error and complications including morbidity and mortality." | 1.39 | Molecular MRI of collagen to diagnose and stage liver fibrosis. ( Caravan, P; Fuchs, BC; Lauwers, GY; Parkar, A; Polasek, M; Schühle, DT; Sinskey, AJ; Tanabe, KK; Wang, H; Wei, L; Yang, Y, 2013) |
| "FHL2(-/-) mice displayed aggravated liver fibrosis compared to wt mice." | 1.39 | Deficiency in four and one half LIM domain protein 2 (FHL2) aggravates liver fibrosis in mice. ( Adam, AC; Büttner, R; Goltz, D; Huss, S; Khlistunova, I; Kirfel, J; Stellmacher, C; Trebicka, J; Weiskirchen, R, 2013) |
| "Dietary cholesterol aggravates liver fibrosis because free cholesterol accumulates in HSCs, leading to increased TLR4 signaling, down-regulation of bone morphogenetic protein and activin membrane-bound inhibitor, and sensitization of HSC to TGFβ." | 1.38 | A high-cholesterol diet exacerbates liver fibrosis in mice via accumulation of free cholesterol in hepatic stellate cells. ( Ebinuma, H; Hibi, T; Hiroi, S; Hokari, R; Irie, R; Kanai, T; Kurihara, C; Miura, S; Okada, Y; Oshikawa, T; Saito, H; Shimamura, K; Sugiyama, K; Suzuki, T; Teratani, T; Tominaga, S; Tomita, K; Yokoyama, H, 2012) |
| "The progression of liver fibrosis results in hepatocellular carcinogenesis in later stages." | 1.38 | Global analysis of DNA methylation in early-stage liver fibrosis. ( Iwasaki, N; Komatsu, Y; Ono, W; Waku, T; Yamaguchi, C; Yanagisawa, J, 2012) |
| "• Liver MR T1ρ decreased when liver fibrosis and injury regressed." | 1.38 | MR T1ρ as an imaging biomarker for monitoring liver injury progression and regression: an experimental study in rats with carbon tetrachloride intoxication. ( Ahuja, AT; Chu, ES; Deng, M; Go, MY; Teng, GJ; Wang, YX; Wong, HL; Yu, J; Yuan, J; Zhao, F, 2012) |
| "Sprague-Dawley rat was induced liver fibrosis by carbon tetrachloride (CCl4) for six weeks together with or without curcumin, and hepatic histopathology and collagen content were employed to quantify liver necro-inflammation and fibrosis." | 1.38 | Inhibition by curcumin of multiple sites of the transforming growth factor-beta1 signalling pathway ameliorates the progression of liver fibrosis induced by carbon tetrachloride in rats. ( Liu, HC; Tu, CT; Wang, JY; Xu, BL; Yao, QY; Zhang, SC, 2012) |
| "Oxidative stress is related to the liver fibrosis, anticipating the hepatic stellate cells' (HSC) activation." | 1.37 | Non-invasive oxidative stress markers for liver fibrosis development in the evolution of toxic hepatitis. ( Catoi, C; Clichici, S; Daicoviciu, D; Decea, N; Filip, A; Gherman, C; Login, C; Mocan, T; Moldovan, R; Muresan, A; Nagy, A, 2011) |
| "These models represent, respectively, a secondary biliary cirrhosis and alcoholic cirrhosis." | 1.35 | Comparison of three research models of portal hypertension in mice: macroscopic, histological and portal pressure evaluation. ( Colle, I; De Vos, M; Geerts, AM; Praet, M; Van Vlierberghe, H; Vanheule, E, 2008) |
| "The extent and kinetic of the disease progression were followed by the measurement of ultrasound backscatter intensity." | 1.34 | Quantitative ultrasonic tissue characterization as a new tool for continuous monitoring of chronic liver remodelling in mice. ( Champy, MF; D'Sa, A; Garo, E; Guimond, A; Monassier, L; Selloum, M; Teletin, M; Vonesch, JL, 2007) |
| "Liver fibrosis was induced by intraperitoneal injection of carbon tetrachloride (CCl(4)), and Cystamine was administrated by intraperitoneal injection starting 2 d before the first administration of CCl(4)." | 1.34 | Cystamine ameliorates liver fibrosis induced by carbon tetrachloride via inhibition of tissue transglutaminase. ( Chen, W; Qiu, JF; Wu, ZY; Zhang, ZQ, 2007) |
| "Gabexate mesilate treatment significantly decreased the elevation of serum transaminase levels and improved liver histology 24 h after the administration of CCl4 (0." | 1.33 | Gabexate mesilate, a synthetic protease inhibitor, attenuates carbon tetrachloride-induced liver injury in rats. ( Goto, T; Kataoka, E; Lin, JG; Mikami, K; Miura, K; Ohshima, S; Segawa, D; Shibuya, T; Watanabe, D; Watanabe, S; Yoneyama, K, 2005) |
| "Pioglitazone treatment was introduced at various time points." | 1.33 | Limited therapeutic efficacy of pioglitazone on progression of hepatic fibrosis in rats. ( Horsmans, Y; Leclercq, IA; Sempoux, C; Stärkel, P, 2006) |
| "In CCL4-induced liver fibrosis model, the correlation between the serum TIMP-1 level and the severity of hepatic fibrosis was not statistically significant(Spearman rank-correlation test, r(s) = 0." | 1.33 | Correlation between TIMP-1 expression and liver fibrosis in two rat liver fibrosis models. ( Li, J; Luo, XD; Nie, QH; Shao, B; Xie, YM; Zhang, YF; Zhou, YX, 2006) |
| "The pathophysiology of acute pancreatitis accompanied by chronic liver injury, and the therapeutic efficacy of prostaglandin (PG)E1 were studied experimentally in rats." | 1.30 | Exacerbation of acute pancreatitis in the presence of chronic liver injury in rats, with special reference to therapeutic efficacy of prostaglandin E1. ( Imamura, M; Mikami, Y; Takahashi, H; Yamauchi, H, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (2.17) | 18.2507 |
| 2000's | 27 (29.35) | 29.6817 |
| 2010's | 56 (60.87) | 24.3611 |
| 2020's | 7 (7.61) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, J | 7 |
| Martin-Mateos, R | 1 |
| Li, J | 6 |
| Yin, Z | 1 |
| Lu, X | 1 |
| Glaser, KJ | 1 |
| Mounajjed, T | 1 |
| Yashiro, H | 1 |
| Siegelman, J | 1 |
| Winkelmann, CT | 1 |
| Wang, J | 1 |
| Ehman, RL | 1 |
| Shah, VH | 1 |
| Yin, M | 2 |
| Maeso-Díaz, R | 1 |
| Boyer-Diaz, Z | 1 |
| Lozano, JJ | 1 |
| Ortega-Ribera, M | 1 |
| Peralta, C | 1 |
| Bosch, J | 1 |
| Gracia-Sancho, J | 1 |
| Zakaria, S | 1 |
| El-Sisi, AE | 1 |
| Zhang, S | 2 |
| Liu, H | 4 |
| Pei, X | 1 |
| Hausser, A | 1 |
| Ishikawa, E | 1 |
| Yamasaki, S | 1 |
| Jin, ZG | 1 |
| Karpińska, G | 1 |
| Dobrowolski, JC | 1 |
| Yinda, CK | 1 |
| Rector, A | 1 |
| Zeller, M | 1 |
| Conceição-Neto, N | 1 |
| Heylen, E | 1 |
| Maes, P | 1 |
| Ghogomu, SM | 1 |
| Van Ranst, M | 1 |
| Matthijnssens, J | 1 |
| Arthanari, SK | 1 |
| Vanitha, J | 1 |
| Ganesh, M | 1 |
| Venkateshwaran, K | 1 |
| de Lama Caro-Patón, G | 1 |
| García-Salido, A | 1 |
| Iglesias-Bouzas, MI | 1 |
| Guillén, M | 1 |
| Cañedo-Villaroya, E | 1 |
| Martínez-Romera, I | 1 |
| Serrano-González, A | 1 |
| Casado-Flores, J | 1 |
| Gale, P | 2 |
| Chen, X | 4 |
| Li, H | 2 |
| Lucero-Prisno, DE | 1 |
| Abdullah, AS | 1 |
| Huang, J | 1 |
| Laurence, C | 1 |
| Liang, X | 1 |
| Ma, Z | 1 |
| Mao, Z | 1 |
| Ren, R | 1 |
| Wu, S | 1 |
| Wang, N | 2 |
| Wang, P | 2 |
| Wang, T | 1 |
| Yan, H | 1 |
| Zou, Y | 1 |
| Olsen, KM | 1 |
| Gabler, NK | 1 |
| Rademacher, CJ | 1 |
| Schwartz, KJ | 1 |
| Schweer, WP | 1 |
| Gourley, GG | 1 |
| Patience, JF | 1 |
| Rauch, JC | 1 |
| Stokes, RS | 1 |
| Shike, DW | 1 |
| Luebbe, KM | 1 |
| Stalker, LA | 1 |
| Klopfenstein, TJ | 1 |
| Funston, RN | 1 |
| Unger, PA | 1 |
| Lighaam, LC | 1 |
| Vermeulen, E | 1 |
| Kruithof, S | 1 |
| Makuch, M | 1 |
| Culver, EL | 1 |
| van Bruggen, R | 1 |
| Remmerswaal, EBM | 1 |
| Ten Berge, IJM | 1 |
| Emmens, RW | 1 |
| Niessen, HWM | 1 |
| Barnes, E | 1 |
| Wolbink, GJ | 1 |
| van Ham, SM | 1 |
| Rispens, T | 1 |
| Liang, JX | 1 |
| Lin, J | 1 |
| Liu, J | 3 |
| Wang, X | 3 |
| Zhang, T | 1 |
| Wu, Y | 4 |
| Venier, M | 1 |
| Salamova, A | 1 |
| Gonçales, VR | 1 |
| Lian, J | 1 |
| Gautam, S | 1 |
| Tilley, RD | 1 |
| Gooding, JJ | 1 |
| Kandel, YR | 1 |
| Bradley, CA | 1 |
| Chilvers, MI | 1 |
| Mathew, FM | 1 |
| Tenuta, AU | 1 |
| Smith, DL | 1 |
| Wise, KA | 1 |
| Mueller, DS | 1 |
| Lu, N | 2 |
| Lu, M | 1 |
| Liu, P | 1 |
| Xu, H | 1 |
| Qiu, X | 1 |
| Hu, S | 1 |
| Bai, S | 1 |
| Wu, J | 1 |
| Xue, S | 1 |
| Dai, X | 1 |
| Dharmage, SC | 1 |
| Abramson, MJ | 1 |
| Erbas, B | 1 |
| Bennett, CM | 1 |
| Svanes, C | 1 |
| Hui, J | 1 |
| Axelrad, C | 1 |
| Lowe, AJ | 1 |
| Lodge, CJ | 1 |
| Hoshi, M | 1 |
| Osawa, Y | 1 |
| Nakamoto, K | 1 |
| Morita, N | 1 |
| Yamamoto, Y | 1 |
| Ando, T | 1 |
| Tashita, C | 1 |
| Nabeshima, T | 1 |
| Saito, K | 1 |
| Gianesello, L | 1 |
| Del Prete, D | 1 |
| Ceol, M | 1 |
| Priante, G | 1 |
| Calò, LA | 1 |
| Anglani, F | 1 |
| Vekaria, HJ | 1 |
| Hubbard, WB | 1 |
| Scholpa, NE | 1 |
| Spry, ML | 1 |
| Gooch, JL | 1 |
| Prince, SJ | 1 |
| Schnellmann, RG | 1 |
| Sullivan, PG | 1 |
| Zhang, Q | 2 |
| Hu, R | 1 |
| Gu, Z | 1 |
| Zhang, M | 3 |
| Zhang, Z | 1 |
| Peng, Y | 1 |
| Feng, L | 1 |
| Li, X | 3 |
| Zhao, C | 1 |
| Sarfaraz, K | 1 |
| Gao, L | 1 |
| Wang, H | 5 |
| Wan, C | 1 |
| Leng, J | 1 |
| Yang, P | 1 |
| Gao, X | 1 |
| Gao, J | 1 |
| Emam, HE | 1 |
| Saad, NM | 1 |
| Abdallah, AEM | 1 |
| Ahmed, HB | 1 |
| Palombo, M | 1 |
| Ianus, A | 1 |
| Guerreri, M | 1 |
| Nunes, D | 1 |
| Alexander, DC | 1 |
| Shemesh, N | 1 |
| Zhang, H | 3 |
| Xiong, Q | 1 |
| Liu, YS | 1 |
| Hu, LX | 1 |
| Shi, ZQ | 1 |
| Ying, GG | 1 |
| Chen, R | 1 |
| Hong, X | 1 |
| Yan, S | 1 |
| Zha, J | 1 |
| Gu, H | 1 |
| Zhong, Q | 1 |
| Zeng, Y | 1 |
| Bu, Y | 1 |
| Farghali, M | 1 |
| Mayumi, M | 1 |
| Syo, K | 1 |
| Satoshi, A | 1 |
| Seiichi, Y | 1 |
| Takashima, S | 1 |
| Ono, H | 1 |
| Ap, Y | 1 |
| Yamashiro, T | 1 |
| Ahmed, MM | 1 |
| Kotb, S | 1 |
| Iwasaki, M | 1 |
| Ihara, I | 1 |
| Umetsu, K | 1 |
| Hu, B | 1 |
| Wang, Y | 7 |
| Quan, J | 1 |
| Huang, K | 3 |
| Gu, X | 2 |
| Zhu, J | 1 |
| Yan, Y | 1 |
| Wu, P | 1 |
| Yang, L | 1 |
| Zhao, J | 1 |
| Koók, L | 1 |
| Nemestóthy, N | 1 |
| Bélafi-Bakó, K | 1 |
| Bakonyi, P | 1 |
| Luo, X | 1 |
| Zhang, F | 1 |
| Li, Q | 1 |
| Xia, Q | 1 |
| Li, Z | 2 |
| Ye, W | 1 |
| Li, S | 3 |
| Ge, C | 1 |
| Zakkula, A | 1 |
| Pulipati, S | 1 |
| Dittakavi, S | 1 |
| Bestha, RM | 1 |
| Zainuddin, M | 1 |
| Trivedi, RK | 1 |
| Mullangi, R | 1 |
| Lo, GH | 1 |
| Lin, CW | 1 |
| Tai, CM | 1 |
| Perng, DS | 1 |
| Chen, IL | 1 |
| Yeh, JH | 1 |
| Lin, HC | 1 |
| Rocha, GS | 1 |
| Silva, MKL | 1 |
| Cesarino, I | 1 |
| Hazzaa, SM | 1 |
| Abdelaziz, SAM | 1 |
| Abd Eldaim, MA | 1 |
| Abdel-Daim, MM | 1 |
| Elgarawany, GE | 1 |
| Larsson, P | 1 |
| Ljuslinder, I | 1 |
| Öhlund, D | 1 |
| Myte, R | 1 |
| Löfgren-Burström, A | 1 |
| Zingmark, C | 1 |
| Ling, A | 1 |
| Edin, S | 1 |
| Palmqvist, R | 1 |
| Murthi, P | 1 |
| Rajaraman, G | 1 |
| Erwich, JJHM | 1 |
| Dimitriadis, E | 1 |
| Yoon, HG | 1 |
| Oh, D | 1 |
| Ahn, YC | 1 |
| Noh, JM | 1 |
| Pyo, H | 1 |
| Cho, WK | 1 |
| Song, YM | 1 |
| Park, M | 1 |
| Hwang, NY | 1 |
| Sun, JM | 1 |
| Kim, HK | 1 |
| Zo, JI | 1 |
| Shim, YM | 1 |
| Persano, A | 1 |
| Quaranta, F | 1 |
| Taurino, A | 1 |
| Siciliano, PA | 1 |
| Iannacci, J | 1 |
| Malekbala, MR | 1 |
| Soltani, S | 1 |
| Abdul Rashid, S | 1 |
| Abdullah, LC | 1 |
| Rashid, U | 1 |
| Nehdi, IA | 1 |
| Choong, TSY | 1 |
| Teo, SH | 1 |
| Xu, P | 1 |
| Yan, F | 1 |
| Zhao, Y | 1 |
| Sun, S | 1 |
| Ying, L | 1 |
| Quinzi, V | 1 |
| Caruso, S | 1 |
| Mummolo, S | 1 |
| Nota, A | 1 |
| Angelone, AM | 1 |
| Mattei, A | 1 |
| Gatto, R | 1 |
| Marzo, G | 1 |
| Xin, W | 1 |
| Severino, J | 1 |
| Venkert, A | 1 |
| Yu, H | 1 |
| Knorr, D | 1 |
| Yang, JM | 1 |
| Carlson, L | 1 |
| Hicks, R | 1 |
| De Rosa, I | 1 |
| Beckmann, NA | 1 |
| Bitsch, RG | 1 |
| Schonhoff, M | 1 |
| Siebenrock, KA | 1 |
| Schwarze, M | 1 |
| Jaeger, S | 1 |
| Trivikram, TM | 1 |
| Niu, ML | 1 |
| Wcisło, P | 1 |
| Ubachs, W | 1 |
| Salumbides, EJ | 1 |
| Sharp, BR | 1 |
| Bowman, DMJS | 1 |
| Palese, A | 1 |
| Bressan, V | 1 |
| Hayter, M | 1 |
| Watson, R | 1 |
| Zhang, Y | 5 |
| Bozorov, TA | 1 |
| Li, DX | 1 |
| Zhou, P | 1 |
| Wen, XJ | 1 |
| Ding, Y | 1 |
| Zhang, DY | 1 |
| Yoshida, H | 1 |
| Koike, M | 1 |
| Tada, Y | 1 |
| Nakata, K | 1 |
| Hino, A | 1 |
| Fuji, S | 1 |
| Masaie, H | 1 |
| Oka, C | 1 |
| Higeno, A | 1 |
| Idota, A | 1 |
| Yamasaki, T | 2 |
| Ishikawa, J | 1 |
| Nekoohesh, L | 2 |
| Ghahremani, MH | 1 |
| Rostami, S | 1 |
| Nikbakht, M | 1 |
| Naemi, R | 1 |
| Mohammadi, S | 1 |
| Ghadyani Nejad, L | 1 |
| Mousavi, SA | 1 |
| Vaezi, M | 1 |
| Alimoghaddam, K | 1 |
| Chahardouli, B | 1 |
| El-Neanaey, WA | 1 |
| Swelem, RS | 1 |
| Ghallab, OM | 1 |
| Mohamed Abu-Shelou, S | 1 |
| Javadzadeh Shahshahani, H | 1 |
| Hayati, A | 1 |
| Abbasnezhad, A | 1 |
| Habibi, M | 1 |
| Abdolkarimi, B | 1 |
| Zare, S | 1 |
| Fazeli Moghadam, E | 1 |
| Choghakhori, R | 1 |
| Asmaa, MJS | 1 |
| Al-Jamal, HA | 1 |
| Hussein, AR | 1 |
| Yahaya, BH | 1 |
| Hassan, R | 1 |
| Hussain, FA | 1 |
| Shamsuddin, S | 1 |
| Johan, MF | 1 |
| Guo, C | 1 |
| Sun, C | 2 |
| Chen, Y | 4 |
| Zhu, H | 1 |
| Xi, J | 1 |
| He, P | 1 |
| Yang, Y | 3 |
| Cuenca, J | 1 |
| Liang, Z | 1 |
| Sun, H | 1 |
| Gutierrez, B | 1 |
| Xi, X | 1 |
| Arro, J | 1 |
| Fan, P | 1 |
| Londo, J | 1 |
| Cousins, P | 1 |
| Fei, Z | 1 |
| Zhong, GY | 1 |
| Bell, K | 1 |
| Rosignol, I | 1 |
| Sierra-Filardi, E | 1 |
| Rodriguez-Muela, N | 1 |
| Schmelter, C | 1 |
| Cecconi, F | 1 |
| Grus, F | 1 |
| Boya, P | 1 |
| Hahn, MA | 1 |
| Von Elert, E | 1 |
| Jiang, Y | 1 |
| Wang, B | 2 |
| Yang, J | 2 |
| Kang, Y | 1 |
| Zhang, WS | 1 |
| Xiong, JH | 1 |
| Kim, HJ | 1 |
| Baek, SK | 1 |
| Maeng, CH | 1 |
| Kim, SY | 1 |
| Park, TS | 1 |
| Han, JJ | 1 |
| Yin, L | 1 |
| Tao, W | 1 |
| Yu, J | 2 |
| Zhou, Q | 1 |
| Mu, H | 1 |
| Shen, Y | 1 |
| Yao, J | 1 |
| Liu, L | 1 |
| Bi, H | 1 |
| Yang, R | 1 |
| Zhou, Z | 1 |
| Yan, B | 1 |
| Li, Y | 1 |
| Min, S | 1 |
| Zhang, P | 2 |
| Xu, B | 1 |
| Wang, Z | 2 |
| Zhang, W | 1 |
| Luo, G | 1 |
| Liu, C | 1 |
| Kim, JK | 1 |
| Lee, HJ | 1 |
| Hwang, SI | 1 |
| Choe, G | 1 |
| Hong, SK | 1 |
| Vaverka, J | 1 |
| Moudr, J | 1 |
| Lokaj, P | 1 |
| Burša, J | 1 |
| Pásek, M | 1 |
| Pham, DC | 1 |
| Nguyen, HC | 1 |
| Nguyen, TL | 1 |
| Ho, HL | 1 |
| Trinh, TK | 1 |
| Riyaphan, J | 1 |
| Weng, CF | 1 |
| Wollin, L | 1 |
| Togbe, D | 1 |
| Ryffel, B | 1 |
| Zhou, X | 2 |
| Cao, H | 1 |
| Yuan, Y | 2 |
| Wu, W | 1 |
| Mao, Y | 1 |
| Xia, B | 1 |
| Long, C | 1 |
| Kuang, X | 1 |
| Huang, H | 1 |
| Ning, J | 1 |
| Ma, X | 1 |
| Wang, R | 2 |
| Tang, H | 1 |
| Du, H | 1 |
| Yan, J | 1 |
| Zhang, X | 1 |
| Shen, H | 1 |
| Almanaitytė, M | 1 |
| Jurevičius, J | 1 |
| Mačianskienė, R | 1 |
| Lu, Y | 2 |
| Chen, L | 2 |
| Li, L | 1 |
| Cao, Y | 2 |
| Han, D | 1 |
| Yu, S | 2 |
| An, C | 1 |
| Liu, X | 3 |
| Zhong, H | 1 |
| Xu, Y | 1 |
| Jiang, L | 1 |
| Wu, LL | 1 |
| Pan, XM | 1 |
| Chen, HH | 1 |
| Fu, XY | 1 |
| Jiang, J | 1 |
| Ding, MX | 1 |
| Ramadan, MZ | 1 |
| Ghaleb, AM | 1 |
| Ragab, AE | 1 |
| Song, F | 2 |
| Lei, X | 1 |
| Li, F | 1 |
| Tan, H | 1 |
| Wang, BJ | 1 |
| Wang, JZ | 1 |
| Xie, XM | 1 |
| Tong, QX | 1 |
| Xu, K | 1 |
| Zhu, Y | 2 |
| Qiao, Y | 1 |
| Li, C | 1 |
| Zeng, R | 1 |
| Ge, G | 1 |
| Liao, YJ | 1 |
| Wang, YH | 1 |
| Wu, CY | 1 |
| Hsu, FY | 1 |
| Chien, CY | 1 |
| Lee, YC | 1 |
| Takemura, S | 1 |
| Azuma, H | 1 |
| Osada-Oka, M | 1 |
| Kubo, S | 1 |
| Shibata, T | 1 |
| Minamiyama, Y | 1 |
| Athwal, VS | 1 |
| Pritchett, J | 1 |
| Llewellyn, J | 1 |
| Martin, K | 1 |
| Camacho, E | 1 |
| Raza, SM | 1 |
| Phythian-Adams, A | 1 |
| Birchall, LJ | 1 |
| Mullan, AF | 1 |
| Su, K | 1 |
| Pearmain, L | 1 |
| Dolman, G | 1 |
| Zaitoun, AM | 1 |
| Friedman, SL | 1 |
| MacDonald, A | 1 |
| Irving, WL | 1 |
| Guha, IN | 1 |
| Hanley, NA | 1 |
| Piper Hanley, K | 1 |
| Hou, F | 1 |
| Liu, R | 2 |
| Cui, L | 1 |
| Yu, X | 1 |
| Wen, Y | 1 |
| Ding, H | 1 |
| Yin, C | 1 |
| Huang, GR | 1 |
| Wei, SJ | 1 |
| Huang, YQ | 1 |
| Xing, W | 1 |
| Wang, LY | 1 |
| Liang, LL | 1 |
| Habib, A | 1 |
| Chokr, D | 1 |
| Wan, J | 1 |
| Hegde, P | 1 |
| Mabire, M | 1 |
| Siebert, M | 1 |
| Ribeiro-Parenti, L | 1 |
| Le Gall, M | 1 |
| Lettéron, P | 1 |
| Pilard, N | 1 |
| Mansouri, A | 2 |
| Brouillet, A | 2 |
| Tardelli, M | 1 |
| Weiss, E | 1 |
| Le Faouder, P | 1 |
| Guillou, H | 1 |
| Cravatt, BF | 1 |
| Moreau, R | 1 |
| Trauner, M | 1 |
| Lotersztajn, S | 1 |
| Sanz-Lázaro, S | 1 |
| Jiménez-Pompa, A | 1 |
| Carmona-Hidalgo, B | 1 |
| Ubeda, M | 1 |
| Muñoz, L | 1 |
| Caba-González, JC | 1 |
| Hernández-Vivanco, A | 1 |
| López-García, S | 1 |
| Albillos, A | 2 |
| Mohseni, R | 1 |
| Karimi, J | 1 |
| Tavilani, H | 1 |
| Khodadadi, I | 1 |
| Hashemnia, M | 1 |
| Jing, F | 1 |
| Geng, Y | 1 |
| Xu, XY | 1 |
| Xu, HY | 1 |
| Shi, JS | 1 |
| Xu, ZH | 1 |
| Ozono, Y | 1 |
| Shide, K | 1 |
| Toyoshima, F | 1 |
| Takaishi, Y | 1 |
| Tsuchimochi, M | 1 |
| Kamiunten, A | 1 |
| Kameda, T | 1 |
| Nakamura, K | 1 |
| Miike, T | 1 |
| Kusumoto, K | 1 |
| Iwakiri, H | 1 |
| Hasuike, S | 1 |
| Nagata, K | 1 |
| Sawaguchi, A | 1 |
| Shimoda, K | 1 |
| Xuan, R | 1 |
| Zhao, X | 1 |
| Jian, J | 1 |
| Hu, D | 1 |
| Qin, L | 1 |
| Lv, W | 1 |
| Hu, C | 1 |
| Hu, M | 1 |
| Xu, L | 1 |
| An, S | 1 |
| Tang, Y | 1 |
| Huang, L | 1 |
| Fuchs, BC | 2 |
| Wei, L | 2 |
| Polasek, M | 1 |
| Schühle, DT | 1 |
| Lauwers, GY | 2 |
| Parkar, A | 1 |
| Sinskey, AJ | 1 |
| Tanabe, KK | 2 |
| Caravan, P | 2 |
| Nussler, AK | 1 |
| Wildemann, B | 1 |
| Freude, T | 1 |
| Litzka, C | 1 |
| Soldo, P | 1 |
| Friess, H | 1 |
| Hammad, S | 1 |
| Hengstler, JG | 1 |
| Braun, KF | 1 |
| Trak-Smayra, V | 1 |
| Godoy, P | 1 |
| Ehnert, S | 1 |
| Ehling, J | 1 |
| Bartneck, M | 1 |
| Wei, X | 1 |
| Gremse, F | 1 |
| Fech, V | 1 |
| Möckel, D | 1 |
| Baeck, C | 2 |
| Hittatiya, K | 1 |
| Eulberg, D | 2 |
| Luedde, T | 2 |
| Kiessling, F | 1 |
| Trautwein, C | 3 |
| Lammers, T | 1 |
| Tacke, F | 3 |
| Hoshida, Y | 1 |
| Fujii, T | 1 |
| Yamada, S | 1 |
| McGinn, CM | 1 |
| DePeralta, DK | 1 |
| Kuroda, T | 1 |
| Lanuti, M | 1 |
| Schmitt, AD | 1 |
| Gupta, S | 1 |
| Crenshaw, A | 1 |
| Onofrio, R | 1 |
| Taylor, B | 1 |
| Winckler, W | 1 |
| Bardeesy, N | 1 |
| Golub, TR | 1 |
| Ding, K | 1 |
| Liu, MR | 1 |
| Liang, Y | 1 |
| Shang, X | 1 |
| Mu, J | 1 |
| Crespo, I | 1 |
| San-Miguel, B | 1 |
| Fernández, A | 1 |
| Ortiz de Urbina, J | 1 |
| González-Gallego, J | 1 |
| Tuñón, MJ | 1 |
| Liu, Y | 1 |
| Tang, A | 1 |
| Miao, D | 1 |
| Yuan, X | 1 |
| Nazeer, SS | 1 |
| Sandhyamani, S | 1 |
| Jayasree, RS | 1 |
| Bansal, R | 1 |
| Frelin, L | 1 |
| Brenndörfer, ED | 1 |
| Storm, G | 1 |
| Prakash, J | 1 |
| Sällberg, M | 1 |
| Getachew, Y | 1 |
| Cusimano, FA | 1 |
| Gopal, P | 1 |
| Reisman, SA | 1 |
| Shay, JW | 1 |
| Hatori, A | 1 |
| Yui, J | 1 |
| Xie, L | 1 |
| Kumata, K | 1 |
| Fujinaga, M | 1 |
| Wakizaka, H | 1 |
| Ogawa, M | 1 |
| Nengaki, N | 1 |
| Kawamura, K | 1 |
| Wang, F | 1 |
| Zhang, MR | 1 |
| Yu, F | 1 |
| Lu, Z | 1 |
| Xu, Z | 1 |
| Chen, B | 1 |
| Dong, P | 1 |
| Zheng, J | 1 |
| Liu, SB | 1 |
| Ikenaga, N | 1 |
| Peng, ZW | 1 |
| Sverdlov, DY | 1 |
| Greenstein, A | 1 |
| Smith, V | 1 |
| Schuppan, D | 3 |
| Popov, Y | 2 |
| Arriazu, E | 1 |
| Ge, X | 1 |
| Leung, TM | 2 |
| Magdaleno, F | 1 |
| Lopategi, A | 1 |
| Kitamura, N | 1 |
| Urtasun, R | 1 |
| Theise, N | 1 |
| Antoine, DJ | 1 |
| Nieto, N | 1 |
| Tabet, E | 1 |
| Genet, V | 1 |
| Tiaho, F | 1 |
| Lucas-Clerc, C | 1 |
| Gelu-Simeon, M | 1 |
| Piquet-Pellorce, C | 1 |
| Samson, M | 1 |
| Wilhelm, A | 1 |
| Shepherd, EL | 1 |
| Amatucci, A | 1 |
| Munir, M | 1 |
| Reynolds, G | 1 |
| Humphreys, E | 1 |
| Resheq, Y | 1 |
| Adams, DH | 1 |
| Hübscher, S | 1 |
| Burkly, LC | 1 |
| Weston, CJ | 1 |
| Afford, SC | 1 |
| Chen, YX | 1 |
| Lai, LN | 1 |
| Zhang, HY | 1 |
| Bi, YH | 1 |
| Meng, L | 1 |
| Li, XJ | 1 |
| Tian, XX | 1 |
| Wang, LM | 1 |
| Fan, YM | 1 |
| Zhao, ZF | 1 |
| Han, DW | 1 |
| Ji, C | 1 |
| Abu-Elsaad, NM | 1 |
| Elkashef, WF | 1 |
| Liu, CH | 1 |
| Chan, KM | 1 |
| Chiang, T | 1 |
| Liu, JY | 1 |
| Chern, GG | 1 |
| Hsu, FF | 1 |
| Wu, YH | 1 |
| Liu, YC | 1 |
| Wang, MJ | 1 |
| Ling, WW | 1 |
| Meng, LW | 1 |
| Cai, H | 1 |
| Peng, B | 1 |
| Kim, YO | 2 |
| Huang, W | 1 |
| Li, R | 1 |
| Yun, Z | 1 |
| Liu, Z | 1 |
| Feng, Q | 1 |
| Hou, J | 1 |
| Zeybel, M | 1 |
| Luli, S | 1 |
| Sabater, L | 1 |
| Hardy, T | 1 |
| Oakley, F | 1 |
| Leslie, J | 1 |
| Page, A | 1 |
| Moran Salvador, E | 1 |
| Sharkey, V | 1 |
| Tsukamoto, H | 1 |
| Chu, DCK | 1 |
| Singh, US | 1 |
| Ponzoni, M | 1 |
| Perri, P | 1 |
| Di Paolo, D | 1 |
| Mendivil, EJ | 1 |
| Mann, J | 1 |
| Mann, DA | 1 |
| Geerts, AM | 1 |
| Vanheule, E | 1 |
| Praet, M | 1 |
| Van Vlierberghe, H | 1 |
| De Vos, M | 1 |
| Colle, I | 1 |
| Natarajan, SK | 2 |
| Amirtharaj, GJ | 1 |
| Ramachandran, A | 2 |
| Pulimood, AB | 2 |
| Balasubramanian, KA | 2 |
| Hosui, A | 1 |
| Kimura, A | 1 |
| Yamaji, D | 1 |
| Zhu, BM | 1 |
| Na, R | 1 |
| Hennighausen, L | 1 |
| Hong, JJ | 1 |
| Pan, FY | 1 |
| Qian, Y | 1 |
| Cheng, LC | 1 |
| Zhang, HX | 1 |
| Xue, B | 1 |
| Li, CJ | 1 |
| Higashiyama, R | 1 |
| Moro, T | 1 |
| Nakao, S | 1 |
| Mikami, K | 2 |
| Fukumitsu, H | 1 |
| Ueda, Y | 1 |
| Ikeda, K | 1 |
| Adachi, E | 1 |
| Bou-Gharios, G | 1 |
| Okazaki, I | 1 |
| Inagaki, Y | 1 |
| Goo, MJ | 1 |
| Ki, MR | 1 |
| Lee, HR | 1 |
| Yang, HJ | 1 |
| Yuan, DW | 1 |
| Hong, IH | 1 |
| Park, JK | 1 |
| Hong, KS | 1 |
| Han, JY | 1 |
| Hwang, OK | 1 |
| Kim, DH | 2 |
| Do, SH | 1 |
| Cohn, RD | 1 |
| Jeong, KS | 1 |
| Mitchell, C | 1 |
| Robin, MA | 1 |
| Mayeuf, A | 1 |
| Mahrouf-Yorgov, M | 1 |
| Hamard, M | 1 |
| Couton, D | 1 |
| Fromenty, B | 1 |
| Gilgenkrantz, H | 1 |
| Jiménez-Anguiano, A | 1 |
| Díaz-Medina, V | 1 |
| Farfán-Labonne, BE | 1 |
| Giono-Chiang, G | 1 |
| Kersenobich, D | 1 |
| García-Lorenzana, M | 1 |
| Gutiérrez-Ruiz, MC | 1 |
| Velázquez-Moctezuma, J | 1 |
| Hintermann, E | 1 |
| Bayer, M | 1 |
| Pfeilschifter, JM | 1 |
| Luster, AD | 1 |
| Christen, U | 1 |
| Onozuka, I | 1 |
| Kakinuma, S | 1 |
| Kamiya, A | 1 |
| Miyoshi, M | 1 |
| Sakamoto, N | 1 |
| Kiyohashi, K | 1 |
| Watanabe, T | 1 |
| Funaoka, Y | 1 |
| Ueyama, M | 1 |
| Nakagawa, M | 1 |
| Koshikawa, N | 1 |
| Seiki, M | 1 |
| Nakauchi, H | 1 |
| Watanabe, M | 1 |
| Fourcot, A | 1 |
| Couchie, D | 1 |
| Chobert, MN | 1 |
| Zafrani, ES | 1 |
| Mavier, P | 1 |
| Laperche, Y | 1 |
| Clichici, S | 1 |
| Catoi, C | 1 |
| Mocan, T | 1 |
| Filip, A | 1 |
| Login, C | 1 |
| Nagy, A | 1 |
| Daicoviciu, D | 1 |
| Decea, N | 1 |
| Gherman, C | 1 |
| Moldovan, R | 1 |
| Muresan, A | 1 |
| Wehr, A | 1 |
| Karlmark, KR | 1 |
| Heymann, F | 1 |
| Vucur, M | 1 |
| Gassler, N | 1 |
| Huss, S | 2 |
| Klussmann, S | 1 |
| Teratani, T | 1 |
| Tomita, K | 1 |
| Suzuki, T | 1 |
| Oshikawa, T | 1 |
| Yokoyama, H | 1 |
| Shimamura, K | 1 |
| Tominaga, S | 1 |
| Hiroi, S | 1 |
| Irie, R | 1 |
| Okada, Y | 1 |
| Kurihara, C | 1 |
| Ebinuma, H | 1 |
| Saito, H | 1 |
| Hokari, R | 1 |
| Sugiyama, K | 1 |
| Kanai, T | 1 |
| Miura, S | 1 |
| Hibi, T | 1 |
| Meng, J | 1 |
| Deng, L | 1 |
| Ma, H | 1 |
| Csete, M | 1 |
| Xiong, L | 1 |
| Knight, V | 1 |
| Tchongue, J | 1 |
| Lourensz, D | 1 |
| Tipping, P | 1 |
| Sievert, W | 1 |
| Reichenbach, V | 2 |
| Ros, J | 2 |
| Fernández-Varo, G | 2 |
| Casals, G | 2 |
| Melgar-Lesmes, P | 2 |
| Campos, T | 1 |
| Makriyannis, A | 1 |
| Morales-Ruiz, M | 2 |
| Jiménez, W | 2 |
| Komatsu, Y | 1 |
| Waku, T | 1 |
| Iwasaki, N | 1 |
| Ono, W | 1 |
| Yamaguchi, C | 1 |
| Yanagisawa, J | 1 |
| Cai, Y | 1 |
| Zhou, CH | 1 |
| Fu, D | 1 |
| Shen, XZ | 1 |
| Meng, F | 1 |
| Wang, K | 1 |
| Aoyama, T | 1 |
| Grivennikov, SI | 1 |
| Paik, Y | 1 |
| Scholten, D | 1 |
| Cong, M | 1 |
| Iwaisako, K | 1 |
| Österreicher, CH | 1 |
| Stickel, F | 1 |
| Ley, K | 1 |
| Brenner, DA | 1 |
| Kisseleva, T | 1 |
| Schattenberg, JM | 1 |
| Nagel, M | 1 |
| Kohl, T | 1 |
| Wörns, MA | 1 |
| Zimmermann, T | 1 |
| Schad, A | 1 |
| Longerich, T | 1 |
| He, YW | 1 |
| Galle, PR | 1 |
| Schuchmann, M | 1 |
| Zhao, F | 1 |
| Wang, YX | 1 |
| Yuan, J | 1 |
| Deng, M | 1 |
| Wong, HL | 1 |
| Chu, ES | 1 |
| Go, MY | 1 |
| Teng, GJ | 1 |
| Ahuja, AT | 1 |
| Oró, D | 1 |
| Weiskirchen, R | 2 |
| Yao, QY | 1 |
| Xu, BL | 1 |
| Wang, JY | 1 |
| Liu, HC | 1 |
| Zhang, SC | 1 |
| Tu, CT | 1 |
| Li, W | 1 |
| Lu, H | 1 |
| Fan, J | 1 |
| Li, D | 1 |
| Stellmacher, C | 1 |
| Goltz, D | 1 |
| Khlistunova, I | 1 |
| Adam, AC | 1 |
| Trebicka, J | 1 |
| Kirfel, J | 1 |
| Büttner, R | 1 |
| Leclercq, IA | 2 |
| Farrell, GC | 1 |
| Schriemer, R | 1 |
| Robertson, GR | 1 |
| Gold, EJ | 1 |
| Francis, RJ | 1 |
| Zimmermann, A | 1 |
| Mellor, SL | 1 |
| Cranfield, M | 1 |
| Risbridger, GP | 1 |
| Groome, NP | 1 |
| Wheatley, AM | 1 |
| Fleming, JS | 1 |
| Streetz, KL | 1 |
| Leifeld, L | 1 |
| Wüstefeld, T | 1 |
| Graw, A | 1 |
| Klein, C | 1 |
| Kamino, K | 1 |
| Spengler, U | 1 |
| Kreipe, H | 1 |
| Kubicka, S | 1 |
| Müller, W | 1 |
| Manns, MP | 1 |
| Limaye, PB | 2 |
| Apte, UM | 2 |
| Shankar, K | 1 |
| Bucci, TJ | 1 |
| Warbritton, A | 1 |
| Mehendale, HM | 4 |
| Thirunavukkarasu, C | 1 |
| Subbotin, VM | 1 |
| Harvey, SA | 1 |
| Fung, J | 1 |
| Gandhi, CR | 1 |
| Lee, KJ | 1 |
| Kim, JY | 1 |
| Jung, KS | 1 |
| Choi, CY | 1 |
| Chung, YC | 1 |
| Jeong, HG | 1 |
| Goto, T | 1 |
| Miura, K | 1 |
| Ohshima, S | 1 |
| Yoneyama, K | 1 |
| Lin, JG | 1 |
| Watanabe, D | 1 |
| Segawa, D | 1 |
| Kataoka, E | 1 |
| Shibuya, T | 1 |
| Watanabe, S | 1 |
| Thomas, S | 1 |
| Sempoux, C | 1 |
| Stärkel, P | 1 |
| Horsmans, Y | 1 |
| Farazi, PA | 1 |
| Glickman, J | 1 |
| Horner, J | 1 |
| Depinho, RA | 1 |
| Nie, QH | 1 |
| Zhang, YF | 1 |
| Xie, YM | 1 |
| Luo, XD | 1 |
| Shao, B | 1 |
| Zhou, YX | 1 |
| Bhave, VS | 3 |
| Palkar, PS | 1 |
| Sawant, SP | 1 |
| Latendresse, JR | 3 |
| Reddy, JK | 1 |
| Ikegami, T | 1 |
| Honda, A | 1 |
| Miyazaki, T | 1 |
| Bouscarel, B | 1 |
| Rojkind, M | 1 |
| Hyodo, I | 1 |
| Matsuzaki, Y | 1 |
| Guimond, A | 1 |
| Teletin, M | 1 |
| Garo, E | 1 |
| D'Sa, A | 1 |
| Selloum, M | 1 |
| Champy, MF | 1 |
| Vonesch, JL | 1 |
| Monassier, L | 1 |
| Qiu, JF | 1 |
| Zhang, ZQ | 1 |
| Chen, W | 1 |
| Wu, ZY | 1 |
| Marumoto, Y | 1 |
| Terai, S | 1 |
| Urata, Y | 1 |
| Matsumoto, T | 1 |
| Mizunaga, Y | 1 |
| Yamamoto, N | 1 |
| Jin, H | 1 |
| Fujisawa, K | 1 |
| Murata, T | 1 |
| Shinoda, K | 1 |
| Nishina, H | 1 |
| Sakaida, I | 1 |
| Donthamsetty, S | 2 |
| Muskhelishvili, L | 1 |
| Tipoe, GL | 1 |
| Liong, EC | 1 |
| Lau, TY | 1 |
| Fung, ML | 1 |
| Nanji, AA | 1 |
| Kanai, S | 1 |
| Okano, H | 1 |
| Takahashi, H | 1 |
| Imamura, M | 1 |
| Mikami, Y | 1 |
| Yamauchi, H | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Does Hepatitis C Management Protect Egyptian Population Against Severe Corona Virus Disease-2019 (COVID-19)?[NCT04757272] | 2,106 participants (Actual) | Observational | 2020-05-01 | Completed | |||
| Quantitative Diagnosis of Liver Fibrosis on Multiparametric MRI[NCT03176797] | 300 participants (Anticipated) | Interventional | 2017-05-03 | Enrolling by invitation | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for carbon tetrachloride and Disease Exacerbation
1 trial available for carbon tetrachloride and Disease Exacerbation
| Article | Year |
|---|---|
Topics: Acetaminophen; Administration, Oral; Adolescent; Adsorption; Adult; Allyl Compounds; Amylopectin; Am | 2013 |
90 other studies available for carbon tetrachloride and Disease Exacerbation
| Article | Year |
|---|---|
Multiparametric magnetic resonance imaging/magnetic resonance elastography assesses progression and regression of steatosis, inflammation, and fibrosis in alcohol-associated liver disease.
Topics: Animals; Carbon Tetrachloride; Collagen; Disease Models, Animal; Disease Progression; Elasticity Ima | 2021 |
New Rat Model of Advanced NASH Mimicking Pathophysiological Features and Transcriptomic Signature of The Human Disease.
Topics: Animals; Carbon Tetrachloride; Diet, High-Fat; Disease Models, Animal; Disease Progression; Fatty Li | 2019 |
Daclatasvir and Sofosbuvir Mitigate Hepatic Fibrosis Through Downregulation of TNF-α / NF-κB Signaling Pathway.
Topics: Animals; Carbamates; Carbon Tetrachloride; Disease Progression; Down-Regulation; Hepatic Stellate Ce | 2020 |
Deletion of Protein Kinase D3 Promotes Liver Fibrosis in Mice.
Topics: Animals; Carbon Tetrachloride; Cells, Cultured; Disease Progression; Hepatic Stellate Cells; Humans; | 2020 |
hsa_circ_0004018 suppresses the progression of liver fibrosis through regulating the hsa-miR-660-3p/TEP1 axis.
Topics: Animals; Benzofurans; Biomarkers; Carbon Tetrachloride; Cell Movement; Cell Proliferation; Cells, Cu | 2020 |
Association of CX3CL1 and CX3CR1 Expression with Liver Fibrosis in a Mouse Model of Schistosomiasis.
Topics: Actins; Animals; Biomarkers; Carbon Tetrachloride; Chemokine CX3CL1; CX3C Chemokine Receptor 1; Dise | 2020 |
Dynamically remodeled hepatic extracellular matrix predicts prognosis of early-stage cirrhosis.
Topics: Animals; Carbon Tetrachloride; Cell Line; Cell Proliferation; Chemical and Drug Induced Liver Injury | 2021 |
Ketogenic Diet Enhances the Cholesterol Accumulation in Liver and Augments the Severity of CCl
Topics: 3-Hydroxybutyric Acid; Acetoacetates; Actins; Animals; Becaplermin; Carbon Tetrachloride; Catalase; | 2021 |
Inhibitory effects of quercetin on the progression of liver fibrosis through the regulation of NF-кB/IкBα, p38 MAPK, and Bcl-2/Bax signaling.
Topics: Alanine Transaminase; Animals; Antioxidants; Aspartate Aminotransferases; bcl-2-Associated X Protein | 2017 |
S-allyl-glutathione improves experimental liver fibrosis by regulating Kupffer cell activation in rats.
Topics: Animals; Carbon Tetrachloride; Cells, Cultured; Chemical and Drug Induced Liver Injury; Collagen Typ | 2018 |
SOX9 predicts progression toward cirrhosis in patients while its loss protects against liver fibrosis.
Topics: Animals; Bile Ducts; Carbon Tetrachloride; Cells, Cultured; Disease Models, Animal; Disease Progress | 2017 |
Arkadia protein expression is reduced in the liver during the progression of hepatic fibrosis.
Topics: Adult; Animals; Bile Ducts; Carbon Tetrachloride; Disease Progression; Female; Humans; Ligation; Liv | 2018 |
Mechanism of combined use of vitamin D and puerarin in anti-hepatic fibrosis by regulating the Wnt/β-catenin signalling pathway.
Topics: Animals; Carbon Tetrachloride; Disease Progression; Drug Synergism; Drug Therapy, Combination; Hepat | 2018 |
Inhibition of monoacylglycerol lipase, an anti-inflammatory and antifibrogenic strategy in the liver.
Topics: Animals; Anti-Inflammatory Agents; Autophagy; Carbamates; Carbon Tetrachloride; Cell Count; Cells, C | 2019 |
The firing frequency of spontaneous action potentials and their corresponding evoked exocytosis are increased in chromaffin cells of CCl
Topics: Action Potentials; Animals; Calcium Channels; Carbon Tetrachloride; Catecholamines; Chromaffin Cells | 2019 |
Carvacrol ameliorates the progression of liver fibrosis through targeting of Hippo and TGF-β signaling pathways in carbon tetrachloride (CCl
Topics: Acyltransferases; Animals; Anti-Inflammatory Agents; Apoptosis Regulatory Proteins; Carbon Tetrachlo | 2019 |
MicroRNA29a Reverts the Activated Hepatic Stellate Cells in the Regression of Hepatic Fibrosis through Regulation of ATPase H⁺ Transporting V1 Subunit C1.
Topics: Adipogenesis; Animals; Carbon Tetrachloride; Cell Transdifferentiation; Disease Progression; Gene Ex | 2019 |
Monocyte-derived fibrocytes elimination had little contribution on liver fibrosis.
Topics: Animals; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Clodronic Acid; Collagen Type | 2019 |
Phase-contrast computed tomography: A correlation study between portal pressure and three dimensional microvasculature of ex vivo liver samples from carbon tetrachloride-induced liver fibrosis in rats.
Topics: Animals; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Computed Tomography Angiograp | 2019 |
Relaxin gene delivery mitigates liver metastasis and synergizes with check point therapy.
Topics: Animals; B7-H1 Antigen; Carbon Tetrachloride; Cell Line, Tumor; Disease Progression; Female; Gene Tr | 2019 |
Molecular MRI of collagen to diagnose and stage liver fibrosis.
Topics: Animals; Carbon Tetrachloride; Collagen Type I; Disease Models, Animal; Disease Progression; Gadolin | 2013 |
Chronic CCl4 intoxication causes liver and bone damage similar to the human pathology of hepatic osteodystrophy: a mouse model to analyse the liver-bone axis.
Topics: Animals; Biomarkers; Bone and Bones; Bone Density; Bone Diseases, Metabolic; Carbon Tetrachloride; C | 2014 |
CCL2-dependent infiltrating macrophages promote angiogenesis in progressive liver fibrosis.
Topics: Animals; Aptamers, Nucleotide; Carbon Tetrachloride; Chemokine CCL2; Disease Models, Animal; Disease | 2014 |
Epidermal growth factor receptor inhibition attenuates liver fibrosis and development of hepatocellular carcinoma.
Topics: Animals; Bile Ducts; Carbon Tetrachloride; Carcinoma, Hepatocellular; Cell Proliferation; Cells, Cul | 2014 |
Establishment of a liver fibrosis model in cynomolgus monkeys.
Topics: Animals; Biopsy; Carbon Tetrachloride; Disease Progression; Hepatocytes; Liver; Liver Cirrhosis, Exp | 2014 |
Melatonin limits the expression of profibrogenic genes and ameliorates the progression of hepatic fibrosis in mice.
Topics: Actins; Animals; Carbon Tetrachloride; Collagen; Cytokines; Disease Progression; Gene Expression; He | 2015 |
Hepatocyte-specific ablation of PP2A catalytic subunit α attenuates liver fibrosis progression via TGF-β1/Smad signaling.
Topics: Animals; Apoptosis; Carbon Tetrachloride; Cell Proliferation; Cells, Cultured; Disease Progression; | 2015 |
Optical diagnosis of the progression and reversal of CCl4-induced liver injury in rodent model using minimally invasive autofluorescence spectroscopy.
Topics: Animals; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Disea | 2015 |
Hepatitis C Virus Nonstructural 3/4A Protein Dampens Inflammation and Contributes to Slow Fibrosis Progression during Chronic Fibrosis In Vivo.
Topics: Acute Disease; Animals; Carbon Tetrachloride; Carrier Proteins; Cell Proliferation; Chronic Disease; | 2015 |
The Synthetic Triterpenoid RTA 405 (CDDO-EA) Halts Progression of Liver Fibrosis and Reduces Hepatocellular Carcinoma Size Resulting in Increased Survival in an Experimental Model of Chronic Liver Injury.
Topics: Animals; Carbon Tetrachloride; Cell Line, Tumor; Cytochrome P-450 CYP2E1; Cytokines; Disease Progres | 2016 |
Utility of Translocator Protein (18 kDa) as a Molecular Imaging Biomarker to Monitor the Progression of Liver Fibrosis.
Topics: Acetamides; Animals; Autoradiography; Biomarkers; Carbon Tetrachloride; Carrier Proteins; Disease Pr | 2015 |
MicroRNA-17-5p-activated Wnt/β-catenin pathway contributes to the progression of liver fibrosis.
Topics: 3' Untranslated Regions; Animals; Benzofurans; Blotting, Western; Carbon Tetrachloride; Cell Line; C | 2016 |
Lysyl oxidase activity contributes to collagen stabilization during liver fibrosis progression and limits spontaneous fibrosis reversal in mice.
Topics: Aminopropionitrile; Animals; Carbon Tetrachloride; Collagen; Collagen Type I; Collagen Type I, alpha | 2016 |
Signalling via the osteopontin and high mobility group box-1 axis drives the fibrogenic response to liver injury.
Topics: Acetylation; Animals; Antibodies, Neutralizing; Carbon Tetrachloride; Case-Control Studies; Cell Nuc | 2017 |
Chlordecone potentiates hepatic fibrosis in chronic liver injury induced by carbon tetrachloride in mice.
Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Biomarkers; Carbon Tetrachloride; Chemic | 2016 |
Interaction of TWEAK with Fn14 leads to the progression of fibrotic liver disease by directly modulating hepatic stellate cell proliferation.
Topics: Actins; Animals; Carbon Tetrachloride; Cell Proliferation; Chemical and Drug Induced Liver Injury; C | 2016 |
Effect of artesunate supplementation on bacterial translocation and dysbiosis of gut microbiota in rats with liver cirrhosis.
Topics: Animals; Anti-Inflammatory Agents; Artemisinins; Artesunate; Bacteria; Bacterial Translocation; Carb | 2016 |
Modified citrus pectin stops progression of liver fibrosis by inhibiting galectin-3 and inducing apoptosis of stellate cells.
Topics: Animals; Antioxidants; Apoptosis; Biomarkers; Carbon Tetrachloride; Citrus; Dietary Fiber; Dietary S | 2016 |
Dual-Functional Nanoparticles Targeting CXCR4 and Delivering Antiangiogenic siRNA Ameliorate Liver Fibrosis.
Topics: Angiogenesis Inhibitors; Animals; Benzylamines; Carbon Tetrachloride; Carcinoma, Hepatocellular; Cyc | 2016 |
Non-invasive evaluation of liver stiffness after splenectomy in rabbits with CCl
Topics: Animals; Biopsy; Carbon Tetrachloride; Disease Progression; Elasticity Imaging Techniques; Fibrosis; | 2016 |
Optimized Mouse Models for Liver Fibrosis.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP-Binding Cassette Sub-Family B Member 4; | 2017 |
Systematic quantification of histological patterns shows accuracy in reflecting cirrhotic remodeling.
Topics: Algorithms; Animals; Carbon Tetrachloride; Diagnostic Imaging; Disease Models, Animal; Disease Progr | 2017 |
A Proof-of-Concept for Epigenetic Therapy of Tissue Fibrosis: Inhibition of Liver Fibrosis Progression by 3-Deazaneplanocin A.
Topics: Adenosine; Animals; Biomarkers; Carbon Tetrachloride; Collagen Type I; Disease Models, Animal; Disea | 2017 |
Comparison of three research models of portal hypertension in mice: macroscopic, histological and portal pressure evaluation.
Topics: Animals; Ascites; Carbon Tetrachloride; Common Bile Duct; Disease Progression; Hypertension, Portal; | 2008 |
Retinoid metabolism in the small intestine during development of liver cirrhosis.
Topics: Alcohol Oxidoreductases; Animals; Biomarkers; Carbon Tetrachloride; Chromatography, High Pressure Li | 2009 |
Loss of STAT5 causes liver fibrosis and cancer development through increased TGF-{beta} and STAT3 activation.
Topics: Animals; Carbon Tetrachloride; Disease Progression; Fibrinogens, Abnormal; Gene Deletion; Haptoglobi | 2009 |
Overexpression of beta-catenin is responsible for the development of portal hypertension during liver cirrhosis.
Topics: Adenoviridae; Animals; beta Catenin; Carbon Tetrachloride; Disease Models, Animal; Disease Progressi | 2009 |
Negligible contribution of bone marrow-derived cells to collagen production during hepatic fibrogenesis in mice.
Topics: Animals; Bone Marrow Cells; Bone Marrow Transplantation; Carbon Tetrachloride; Cell Differentiation; | 2009 |
Helicobacter pylori promotes hepatic fibrosis in the animal model.
Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Biomarkers; Calcium-Binding Proteins; Ca | 2009 |
Protection against hepatocyte mitochondrial dysfunction delays fibrosis progression in mice.
Topics: Animals; Apoptosis; Biomarkers; Carbon Tetrachloride; Caspases; Disease Progression; Fibrosis; Hepat | 2009 |
Modification of sleep architecture in an animal model of experimental cirrhosis.
Topics: Animals; Carbon Tetrachloride; Disease Models, Animal; Disease Progression; Dose-Response Relationsh | 2009 |
CXCL10 promotes liver fibrosis by prevention of NK cell mediated hepatic stellate cell inactivation.
Topics: Animals; Antibodies, Blocking; Carbon Tetrachloride; Cell Movement; Cell Proliferation; Chemokine CX | 2010 |
Cholestatic liver fibrosis and toxin-induced fibrosis are exacerbated in matrix metalloproteinase-2 deficient mice.
Topics: Actins; Animals; Carbon Tetrachloride; Cholestasis; Collagen Type I; Disease Progression; Liver Cirr | 2011 |
Gas6 deficiency prevents liver inflammation, steatohepatitis, and fibrosis in mice.
Topics: Animals; Axl Receptor Tyrosine Kinase; Carbon Tetrachloride; Cell Proliferation; Choline Deficiency; | 2011 |
Non-invasive oxidative stress markers for liver fibrosis development in the evolution of toxic hepatitis.
Topics: Animals; Biomarkers; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Disease Models, A | 2011 |
Pharmacological inhibition of the chemokine CCL2 (MCP-1) diminishes liver macrophage infiltration and steatohepatitis in chronic hepatic injury.
Topics: Acute Disease; Animals; Aptamers, Nucleotide; Bone Marrow Cells; Carbon Tetrachloride; Cells, Cultur | 2012 |
A high-cholesterol diet exacerbates liver fibrosis in mice via accumulation of free cholesterol in hepatic stellate cells.
Topics: Animals; Apoptosis; Bile Ducts; Carbon Tetrachloride; Cholesterol, Dietary; Disease Models, Animal; | 2012 |
ED50 and recovery times after propofol in rats with graded cirrhosis.
Topics: Alanine Transaminase; Anesthetics, Intravenous; Animals; Aspartate Aminotransferases; Biomarkers; Ca | 2012 |
Protease-activated receptor 2 promotes experimental liver fibrosis in mice and activates human hepatic stellate cells.
Topics: Animals; Carbon Tetrachloride; Cell Proliferation; Cells, Cultured; Collagen; Cytokines; Disease Mod | 2012 |
Prevention of fibrosis progression in CCl4-treated rats: role of the hepatic endocannabinoid and apelin systems.
Topics: Animals; Apelin; Apelin Receptors; Apoptosis; Blood Pressure; Cannabinoid Receptor Modulators; Carbo | 2012 |
Global analysis of DNA methylation in early-stage liver fibrosis.
Topics: Animals; Carbon Tetrachloride; Carcinoma, Hepatocellular; Chromosomes, Mammalian; Computational Biol | 2012 |
Overexpression of Smad ubiquitin regulatory factor 2 suppresses transforming growth factor-β mediated liver fibrosis.
Topics: Animals; Carbon Tetrachloride; Cells, Cultured; Collagen; Disease Progression; Gene Expression Regul | 2012 |
Interleukin-17 signaling in inflammatory, Kupffer cells, and hepatic stellate cells exacerbates liver fibrosis in mice.
Topics: Animals; Bile Ducts; Bone Marrow Transplantation; Carbon Tetrachloride; Cell Line; Collagen Type I; | 2012 |
Increased hepatic fibrosis and JNK2-dependent liver injury in mice exhibiting hepatocyte-specific deletion of cFLIP.
Topics: Animals; Apoptosis; Carbon Tetrachloride; CASP8 and FADD-Like Apoptosis Regulating Protein; Caspase | 2012 |
MR T1ρ as an imaging biomarker for monitoring liver injury progression and regression: an experimental study in rats with carbon tetrachloride intoxication.
Topics: Animals; Biomarkers; Carbon Tetrachloride; Disease Progression; Inflammation; Liver; Liver Cirrhosis | 2012 |
Adenoviral dominant-negative soluble PDGFRβ improves hepatic collagen, systemic hemodynamics, and portal pressure in fibrotic rats.
Topics: Actins; Adenoviridae; Animals; beta-Galactosidase; Carbon Tetrachloride; Collagen; Disease Models, A | 2012 |
Inhibition by curcumin of multiple sites of the transforming growth factor-beta1 signalling pathway ameliorates the progression of liver fibrosis induced by carbon tetrachloride in rats.
Topics: Animals; Carbon Tetrachloride; Curcuma; Curcumin; Disease Progression; Down-Regulation; Humans; Live | 2012 |
Coexpression of Smad7 and UPA attenuates carbon tetrachloride-induced rat liver fibrosis.
Topics: Adenoviridae; Animals; Carbon Tetrachloride; Cell Proliferation; Disease Progression; Extracellular | 2012 |
Deficiency in four and one half LIM domain protein 2 (FHL2) aggravates liver fibrosis in mice.
Topics: Animals; Apoptosis; Carbon Tetrachloride; Cell Movement; Cells, Cultured; Disease Models, Animal; Di | 2013 |
Leptin is essential for the hepatic fibrogenic response to chronic liver injury.
Topics: Animals; Carbon Tetrachloride; Chronic Disease; Disease Progression; Fatty Liver; Female; Leptin; Li | 2002 |
Changes in activin and activin receptor subunit expression in rat liver during the development of CCl4-induced cirrhosis.
Topics: Activin Receptors, Type II; Animals; Apoptosis; Carbon Tetrachloride; Disease Progression; Gene Expr | 2003 |
Interleukin 6/gp130-dependent pathways are protective during chronic liver diseases.
Topics: Acute Disease; Adolescent; Adult; Aged; Animals; Antigens, CD; Carbon Tetrachloride; Cell Division; | 2003 |
Calpain released from dying hepatocytes mediates progression of acute liver injury induced by model hepatotoxicants.
Topics: Acetaminophen; Animals; Blotting, Western; Calpain; Carbon Tetrachloride; Carrier Proteins; Chemical | 2003 |
Endothelin receptor antagonist TAK-044 arrests and reverses the development of carbon tetrachloride induced cirrhosis in rats.
Topics: Animals; Carbon Tetrachloride; Disease Progression; Endothelin Receptor Antagonists; Endothelin-1; H | 2004 |
Suppressive effects of Platycodon grandiflorum on the progress of carbon tetrachloride-induced hepatic fibrosis.
Topics: Animals; Carbon Tetrachloride; Cells, Cultured; Disease Progression; Dose-Response Relationship, Dru | 2004 |
Gabexate mesilate, a synthetic protease inhibitor, attenuates carbon tetrachloride-induced liver injury in rats.
Topics: Animals; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Disea | 2005 |
Retinoid metabolism during development of liver cirrhosis.
Topics: Aging; Animals; Carbon Tetrachloride; Disease Progression; Female; Liver Cirrhosis, Experimental; Ma | 2005 |
Limited therapeutic efficacy of pioglitazone on progression of hepatic fibrosis in rats.
Topics: Animals; Bile Ducts; Carbon Tetrachloride; Choline; Collagen Type I; Disease Progression; Hypoglycem | 2006 |
Cooperative interactions of p53 mutation, telomere dysfunction, and chronic liver damage in hepatocellular carcinoma progression.
Topics: Alleles; Animals; Carbon Tetrachloride; Carbon Tetrachloride Poisoning; Disease Models, Animal; Dise | 2006 |
Correlation between TIMP-1 expression and liver fibrosis in two rat liver fibrosis models.
Topics: Animals; Carbon Tetrachloride; Disease Models, Animal; Disease Progression; Enzyme-Linked Immunosorb | 2006 |
Upregulation of calpastatin in regenerating and developing rat liver: role in resistance against hepatotoxicity.
Topics: Acetaminophen; Animals; Animals, Newborn; Calcium-Binding Proteins; Calpain; Carbon Tetrachloride; C | 2006 |
Involvement of integrin-linked kinase in carbon tetrachloride-induced hepatic fibrosis in rats.
Topics: Animals; Apoptosis; Blotting, Western; Carbon Tetrachloride; Cell Proliferation; Cells, Cultured; Di | 2006 |
Quantitative ultrasonic tissue characterization as a new tool for continuous monitoring of chronic liver remodelling in mice.
Topics: Animals; Bile Ducts; Carbon Tetrachloride; Collagen; Disease Models, Animal; Disease Progression; Fe | 2007 |
Cystamine ameliorates liver fibrosis induced by carbon tetrachloride via inhibition of tissue transglutaminase.
Topics: Actins; Animals; Carbon Tetrachloride; Collagen; Cystamine; Disease Progression; Enzyme Inhibitors; | 2007 |
Continuous high expression of XBP1 and GRP78 is important for the survival of bone marrow cells in CCl4-treated cirrhotic liver.
Topics: Animals; Blotting, Western; Bone Marrow Cells; Bone Marrow Transplantation; Carbon Tetrachloride; Ce | 2008 |
Secretory phospholipase A2 mediates progression of acute liver injury in the absence of sufficient cyclooxygenase-2.
Topics: Acute Disease; Alanine Transaminase; Animals; Carbon Tetrachloride; Carbon Tetrachloride Poisoning; | 2008 |
Inhibition of cyclooxygenase-2 aggravates secretory phospholipase A2-mediated progression of acute liver injury.
Topics: Acute Disease; Alanine Transaminase; Animals; Blotting, Western; Carbon Radioisotopes; Carbon Tetrac | 2008 |
Endothelial nitric oxide synthase is a critical factor in experimental liver fibrosis.
Topics: Alanine Transaminase; Animals; Arginine; Blotting, Western; Carbon Tetrachloride; Chronic Disease; D | 2008 |
Mechanism of the protective effects of sumac gall extract and gallic acid on the progression of CCl4-induced acute liver injury in rats.
Topics: Acute Disease; Administration, Inhalation; Administration, Oral; Animals; Carbon Tetrachloride; Chem | 1998 |
Exacerbation of acute pancreatitis in the presence of chronic liver injury in rats, with special reference to therapeutic efficacy of prostaglandin E1.
Topics: Acute Disease; alpha-Macroglobulins; Alprostadil; Amylases; Animals; Biomarkers; Carbon Tetrachlorid | 1999 |